We have collected information about Tumor-Targeted Delivery Of Biologically Active Trail Protein for you. Follow the links to find out details on Tumor-Targeted Delivery Of Biologically Active Trail Protein.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2859322/
Apr 19, 2010 · Tumor-targeted delivery of biologically active TRAIL protein. ... and intravenous injection of sTRAIL-expressing E. coli DH5α results in the tumor-targeted release of biologically active molecules, which leads to a dramatic reduction in the tumor growth rate and the prolonged survival of …Author: H. Y. Zhang, J. H. Man, B. Liang, T. Zhou, C. H. Wang, T. Li, H. Y. Li, W. H. Li, B. F. Jin, Peijing...
https://www.nature.com/articles/cgt200976
Jan 15, 2010 · The tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is a type-II transmembrane protein that was initially identified based on homology of …Author: H. Y. Zhang, J. H. Man, B. Liang, T. Zhou, C. H. Wang, T. Li, H. Y. Li, W. H. Li, B. F. Jin, Peijing...
https://www.researchgate.net/publication/41028946_Tumor-targeted_delivery_of_biologically_active_TRAIL_protein
Tumor-targeted delivery of biologically active TRAIL protein Article (PDF Available) in Cancer gene therapy 17(5):334-43 · May 2010 with 75 Reads How we measure 'reads'
https://mdanderson.elsevierpure.com/en/publications/tumor-targeted-delivery-of-biologically-active-trail-protein
With the high tumor-targeting nature, we demonstrate that intratumoral (i.t.) and intravenous injection of sTRAIL-expressing E. coli DH5α results in the tumor-targeted release of biologically active molecules, which leads to a dramatic reduction in the tumor growth rate and the prolonged survival of …Author: H. Y. Zhang, J. H. Man, B. Liang, T. Zhou, C. H. Wang, T. Li, H. Y. Li, W. H. Li, B. F. Jin, Peijing...
http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.354.6352
CiteSeerX - Document Details (Isaac Councill, Lee Giles, Pradeep Teregowda): Tumor-targeted delivery of biologically active TRAIL protein ... {P-j Zhang and J Zhao and X Pan and K He and W-l Gong and X-m Zhang and A-l Li}, title = {ORIGINAL ARTICLE ... Tumor-targeted delivery of biologically active TRAIL protein. Keyphrases. original article ...
https://www.sciencedirect.com/science/article/pii/S0168365915302972
Prostate cancer, once it has progressed from its local to metastatic form, is a disease with poor prognosis and limited treatment options. Here we demonstrate an approach using nanoscale liposomes conjugated with E-selectin adhesion protein and Apo2L/TRAIL (TNF-related apoptosis-inducing ligand) apoptosis ligand that attach to the surface of leukocytes and rapidly clear viable cancer cells ...Author: Elizabeth C. Wayne, Siddarth Chandrasekaran, Michael J. Mitchell, Maxine F. Chan, Rachel E. Lee, Chr...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681880/
First we used it to deliver a marker protein, enhanced green fluorescent protein (GFP) to the surface of keratinocytes in normal epidermis. Once we showed that was feasible, we then used it to deliver biologically active tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).Author: Michiyoshi Kouno, Chenyan Lin, Norman Schechter, Don Siegel, Xiaoping Yang, John T. Seykora, John R ...
https://link.springer.com/article/10.1007/s00109-013-1093-2
Oct 26, 2013 · The novel fusion protein sTRAIL-TMTP1 exhibits a targeted inhibition of primary tumors and metastases ... Liang B, Zhou T, Wang CH, Li T, Li HY, Li WH, Jin BF, Zhang PJ et al (2010) Tumor-targeted delivery of biologically active TRAIL protein. Cancer Gene Ther 17:334–343 ... The novel fusion protein sTRAIL-TMTP1 exhibits a targeted inhibition ...Author: Ronghua Liu, Xiangyi Ma, Hongyan Wang, Yandong Xi, Min Qian, Wanhua Yang, Danfeng Luo, Liangsheng Fa...
https://www.sciencedirect.com/science/article/pii/S0168365915302571
Using this synthetic inter-kingdom expression platform, intracellular delivery and expression of various cargos could be achieved to assess their therapeutic potential. ST3 harboring different therapeutic candidates (Table S3), either protein, DNA or RNA, were used to deliver their cargos into MDA-MB-231 breast cancer cells.Author: Lei Shi, Bin Yu, Bin Yu, Chun-Hui Cai, Chun-Hui Cai, Wei Huang, Bo-Jian Zheng, David Keith Smith, Ji...
https://www.researchgate.net/publication/258043641_The_novel_fusion_protein_sTRAIL-TMTP1_exhibits_a_targeted_inhibition_of_primary_tumors_and_metastases
The novel fusion protein sTRAIL-TMTP1 exhibits a targeted inhibition of primary tumors and metastases. ... Tumor-targeted delivery of biologically active TRAIL protein. Article.
Searching for Tumor-Targeted Delivery Of Biologically Active Trail Protein?
You can just click the links above. The data is collected for you.
